Childhood Cancer Predisposition and Evolutionary Constraints: Novel Lessons from Germline Genomes from 1,127 Children
Ulrik Kristoffer Stoltze1,2,3, Thomas van Overeem Hansen2,4, Jon Foss-Skiftesvik1,5
1Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Genomic analysis reveals a higher-than-expected rate of pathogenic variants in cancer predisposition syndromes (CPSs) in children with cancer. This highlights the importance of germline genomic testing for early diagnosis and personalized pediatric oncology care.
Area of Science:
- Genomics
- Pediatric Oncology
- Evolutionary Biology
Background:
- Cancer predisposition syndromes (CPSs) are a major cause of childhood cancers and influence treatment strategies.
- Previous pediatric cancer studies have not fully utilized genomic evolutionary metrics to predict disease penetrance or identify new CPSs.
Purpose of the Study:
- To investigate the utility of genomic evolutionary metrics in predicting cancer predisposition syndrome penetrance.
- To identify novel cancer predisposition syndromes using an evolution-guided approach.
Main Methods:
- Germline whole-genome sequencing (WGS) was performed on a prospective cohort of children diagnosed with cancer before age 18.
- Evolution-guided burden analysis compared private germline variants in constrained genes against a large reference exome dataset (gnomAD).
Main Results:
- 16% of 1,127 participants carried a pathogenic variant in a CPS gene; 9% of 651 children had a causative variant, a significantly higher rate than previously reported.
- An excess of loss-of-function (LoF) variants was observed in constrained genes compared to reference adults, indicating negative Darwinian selective pressure.
- A significant residual enrichment of pLoF variants was found in genes evolutionarily least tolerant to damage, exceeding expectations.
Conclusions:
- The high prevalence of LoF variants in CPS genes underscores the necessity of routine germline genomic profiling for childhood cancer patients.
- Linking genomic data with clinical phenotypes is crucial for advancing pediatric oncology care and enabling pre-diagnostic interventions.
More Related Videos
Related Concept Videos
Cancer Prevention
Some...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...


